Development of New Chronopharmacotherapies Based on Biological Rhythm

Jan 4, 2003Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

Developing new medicines that work with the body's natural daily rhythms

AI simplified

Abstract

Interferon disrupts the rhythm of locomotor activity, body temperature, and clock gene expression in mammals.

  • The mammalian circadian pacemaker is located in the suprachiasmatic nuclei (SCN).
  • Clock genes manage circadian rhythms that influence physiology and behavior.
  • Drug effectiveness and toxicity may vary based on the timing of administration relative to circadian rhythms.
  • Monitoring rhythmic markers could aid in selecting optimal dosing times for medications.
  • Some drugs can negatively impact 24-hour rhythms, potentially leading to health issues.
  • Dosing schedules that minimize the adverse effects on clock function may enhance chronopharmacotherapy.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free